paraoxon has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jelic-Ivanovic, Z; Kalimanovska-Ostric, D; Kotur-Stevuljevic, J; Memon, L; Spasic, S; Spasojevic-Kalimanovska, V; Stefanovic, A; Vujovic, A | 1 |
| Colley, CM; Mackness, MI; McElveen, J; Peard, T; Walker, CH; Warner, S | 1 |
2 other study(ies) available for paraoxon and Coronary Disease
| Article | Year |
|---|---|
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Topics: Aryldialkylphosphatase; Coronary Disease; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Organophosphorus Compounds; Oxidative Stress; Paraoxon; Phenotype | 2008 |
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
Topics: Aryldialkylphosphatase; Coronary Disease; Female; Humans; Kinetics; Male; Myocardial Infarction; Paraoxon; Phosphoric Monoester Hydrolases | 1986 |